Murilo Freitas – Page 23

Medtronic Recalls StealthStation S8 Application Versions 1.2.0, 1.1.0, 1.0.3, 1.0.2, and 1.0.1 for Software Error that May Cause Incorrect Measurements During Cranial Surgery

Murilo Freitas - 04:00, 4 de June de 2024291

The software error may cause numbers or letters to be missing from the displayed text and may result in the mechanical depth stop being set too short or too long.

http://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-stealthstation-s8-application-versions-120-110-103-102-and-101-software-error-may

rss

HomeoCare Laboratories Inc. Issues Voluntary Nationwide Recall of Homeopathic Stella Life Oral Care Spray Unflavored and Advanced Formula Peppermint Oral Care Rinse Due to Microbial Contamination

Murilo Freitas - 04:00, 4 de June de 2024210

HomeoCare Laboratories Inc., a manufacturer of homeopathic products, is voluntarily recalling two batches of Homeopathic StellaLife Oral Care Products listed in the table below manufactured in 2024 due to FDA findings of microbial contamination. This recall is to be performed at the consumer level.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/homeocare-laboratories-inc-issues-voluntary-nationwide-recall-homeopathic-stella-life-oral-care

rss

FDA Roundup: June 4, 2024

Murilo Freitas - 18:27, 3 de June de 2024197

FDA Roundup: June 4, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-4-2024

rss

FDA Roundup: May 31, 2024

Murilo Freitas - 19:21, 30 de May de 2024261

FDA Roundup: May 31, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-31-2024

rss

Medline Industries, LP Issues Nationwide Recall of SubG Endotracheal Tube with Subglottic Suction

Murilo Freitas - 04:00, 30 de May de 2024240

On February 20, 2024, Medline Industries, LP initiated a nationwide recall of 6 SubG Endotracheal Tubes with Subglottic Suction and 10 kits that contain these devices. The inflation tube and other device components have become detached and/or torn from the main tube, resulting in moisture buildup, l

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/medline-industries-lp-issues-nationwide-recall-subg-endotracheal-tube-subglottic-suction

rss

FDA, USDA, EPA enhance efforts to reduce food loss and waste, welcome USAID to interagency collaborative

Murilo Freitas - 20:31, 29 de May de 2024274

FDA, USDA, EPA enhance efforts to reduce food loss and waste, welcome USAID to interagency collaborative
http://www.fda.gov/news-events/press-announcements/fda-usda-epa-enhance-efforts-reduce-food-loss-and-waste-welcome-usaid-interagency-collaborative

rss

FDA’s Reorganization Approved for Establishing Unified Human Foods Program, New Model for Field Operations and Other Modernization Efforts

Murilo Freitas - 15:28, 29 de May de 2024203

FDA’s Reorganization Approved for Establishing Unified Human Foods Program, New Model for Field Operations and Other Modernization Efforts
http://www.fda.gov/news-events/press-announcements/fdas-reorganization-approved-establishing-unified-human-foods-program-new-model-field-operations-and

rss

OptumHealth Care Solutions Recalls Nimbus II Infusion Pump Systems Under Recall by InfuTronix, LLC

Murilo Freitas - 04:00, 29 de May de 2024219

Nimbus II infusion pumps may experience one or more issues that can cause severe patient injury and death.

http://www.fda.gov/medical-devices/medical-device-recalls/optumhealth-care-solutions-recalls-nimbus-ii-infusion-pump-systems-under-recall-infutronix-llc

rss

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to Potential Presence of Particulate Matter

Murilo Freitas - 04:00, 28 de May de 2024218

Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection, USP (80 mg per 8 mL multi-dose vials and 160 mg per 16 mL multi-dose vials). The product was distributed by Sagent Pharmaceuticals. Sagent has initiated this voluntary recall of Docetaxel Injec

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sagent-pharmaceuticals-issues-voluntary-nationwide-recall-docetaxel-injection-usp-due-potential

rss

FDA Approves First Interchangeable Biosimilar for Two Rare Diseases

Murilo Freitas - 22:06, 27 de May de 2024302

FDA Approves First Interchangeable Biosimilar for Two Rare Diseases
http://www.fda.gov/news-events/press-announcements/fda-approves-first-interchangeable-biosimilar-two-rare-diseases